Oppenheimer & CO Inc Ampio Pharmaceuticals, Inc. Transaction History

Oppenheimer & CO Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$0.16 - $0.47 $16 - $47	-100 Reduced 0.4%	25,000 $4,000
Q4 2020 Feb 11, 2021	BUY	$0.75 - $2.76 $18,825 - $69,276	25,100 New	25,100 $40,000
Q3 2020 Nov 13, 2020	SELL	$0.61 - $1.17 $6,161 - $11,817	-10,100 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$1.66 - $3.82 $21,414 - $49,278	-12,900 Reduced 56.09%	10,100 $22,000
Q1 2018 May 01, 2018	BUY	$2.16 - $3.48 $6,480 - $10,440	3,000 Added 15.0%	23,000 $78,000
Q3 2017 Nov 09, 2017	BUY	$0.38 - $0.66 $7,600 - $13,200	20,000	20,000 $12,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.